Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

16 Jun 2026 · Qiran Gabrielle-Grace
HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations
On Wednesday, 3 June 2026, HealthInvest brought the life sciences and investment communities back together in Sydney.
Read article
19 May 2026 · Qiran Gabrielle-Grace
HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
The ASX healthcare and life sciences sector remains a powerhouse of innovation. To spotlight the companies driving this momentum, HealthInvest returns for 2026.
Read article
30 Apr 2026 · Jane Lowe
Lifesaving Capital: How impact investing is shaping the future of biotech
At the recent Impact Investment Summit in Sydney, a panel on impact investing in biotech tackled a critical question: how do we fund the science that can save lives?
Read article28 Aug 2024 · Qiran Gabrielle-Grace
HealthInvest 2024
This year's event promises to be a compelling experience, featuring presentations from some of the most innovative companies in the industry, including Clarity Pharmaceuticals, Percheron Therapeutics,...
Read article
13 Jan 2022 · Admin
IRD Invest - Innovation and change
We are all part of a new era. After reaching a low point in mid-2020, the investment landscape has changed dramatically. Companies, like investment markets, are adapting. We want to illustrate how our...
Read article
20 Oct 2021
Surge in growth stocks lifts investor relations activity
2021 has been a record year for the number of initial public offerings (IPOs), with more than 130 on the ASX so far and dozens more anticipated by the end of December. The heightened IPO activity was ...
Read article
21 Sep 2021 · Jane Lowe
Atomo Diagnostics (ASX: AT1) presents at IRD Invest
Atomo has supply agreements in place for tests targeting infectious diseases including HIV, COVID-19, and viral vs bacterial differentiation.
Read article
12 Aug 2021 · George Kopsiaftis
What will investors be looking out for this reporting period?
With another financial reporting season upon us, we thought it an opportune time to consider what the investment community will likely be focusing on as they contemplate how best to position their…
Read article
15 Dec 2020 · Admin
Biotech 2020
Thanks to all those presenters and investors who made time to attend IRD Invest , IR Department’s virtual investor conference o n 29 July 2020. Replays of the presentations are available via the…
Read article
26 Oct 2020
Tesserent presents at IRD Invest
Tesserent provides full service, enterprise-grade Cyber Security and networking solutions targeted at midmarket, enterprise and government customers across Australia. The Company’s Cyber 360 strateg...
Read article